• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Can lomustine replace radiation therapy in treating incompletely excised mast cell tumors?

March 16, 2009

Dogs with incompletely excised grade 1 and 2 mast cell tumors that are ineligible for a second surgery may undergo radiation therapy to help prevent recurrence or metastasis. But this form of therapy is expensive, inaccessible to many practitioners, and inappropriate in sensitive areas because it can cause painful skin reactions.

Untitled Document

Dogs with incompletely excised grade 1 and 2 mast cell tumors that are ineligible for a second surgery may undergo radiation therapy to help prevent recurrence or metastasis. But this form of therapy is expensive, inaccessible to many practitioners, and inappropriate in sensitive areas because it can cause painful skin reactions. Chemotherapy may be a good alternative, and a recent study in the Journal of the American Animal Hospital Association retrospectively analyzed whether lomustine (CCNU), with or without prednisone, is as effective as radiation therapy in this situation. The authors found 12 cases that fit their criteria-grade 2 mast cell tumors with or without metastases, incomplete surgical excision, and lomustine given with or without prednisone within two months of surgery. The median initial lomustine dose was 60 mg/m2 every three weeks. The dosage was decreased or the interval prolonged in some dogs because of neutropenia or increased serum alanine transaminase (ALT) activity, so the median dose intensity was 17 mg/m2/week. Eleven of the dogs received concurrent prednisone (40 mg/m2/day for seven days, then 20 mg/m2 every other day). The median treatment duration was 6.3 months with a median of eight lomustine doses. Three of the dogs did not complete the treatment course because of increased ALT activity.

Overall, lomustine was effective-the one-year progression-free interval was 100%, and the two-year interval was 77%. None of the dogs experienced local recurrence or regional or distant metastases. The treatment was generally well-tolerated-two dogs developed grade 3 neutropenia and three dogs had grade 2 diarrhea, with one of those dogs experiencing concurrent grade 1 vomiting, anorexia, and lethargy. Of concern was lomustine's hepatotoxicity-one dog developed grade 4 hepatotoxicosis and two dogs died of hepatic disease. However, the dogs that died received high cumulative lomustine doses without having their serum ALT activities monitored. No dog in which serum ALT activity was monitored closely developed liver failure. In the authors' practice, lomustine therapy is discontinued or adjusted if the serum ALT activity exceeds 250 IU/L, and treatment length does not exceed 6 months. Although the authors point out that the size of this sample population was small and that lomustine treatment and monitoring guidelines warrant study on a larger scale, they do think lomustine is a good adjuvant therapy for incompletely excised mast cell tumors.  

Advertisement

Hosoya K, Kisseberth WC, Alvarez FJ, et al. Adjuvant CCNU (lomustine) and prednisone chemotherapy for dogs with incompletely excised grade 2 mast cell tumors. J Am Anim Hosp Assoc 2009;45:14-18.

Link to abstract: http://www.jaaha.org/cgi/content/abstract/45/1/14

Related Content:

Oncology
Feline oral cancer is the focus of a new study
Feline oral cancer is the focus of a new study
Advances in the detection, characterization, and monitoring of cancer in pets
Advances in the detection, characterization, and monitoring of cancer in pets
Volition's Nu.Q Vet Cancer Test now available for preorder at point-of-care via Heska Corporation
Volition's Nu.Q Vet Cancer Test now available for preorder at point-of-care via Heska Corporation

Advertisement

Latest News

Pet Advocacy Network honors outstanding contributions to the pet care community

Traditional and holistic treatments for giardia

ASU trustees approve the creation of a new veterinary school

6 tips for first-time dog owners

View More Latest News
Advertisement